Day Tradexchange Inc
Change company Symbol lookup
Select an option...
SYNJ Day Tradexchange Inc
NVEC NVE Corp
BAC Bank of America Corp
TTWO Take-Two Interactive Software Inc
CYBE CyberOptics Corp
SJM J M Smucker Co
NKORF Nickel One Resources Inc
NFLX Netflix Inc
MXIM Maxim Integrated Products Inc
MS Morgan Stanley
Go

Company profile

Day Tradexchange, Inc., formerly Syndication, Inc., is a consulting company engaged in acquiring controlling interest in or to participate in the creation of, and to provide financial management and technical support to development stage business, e-commerce businesses, and traditional brick and mortar businesses. It specializes in project development services for private and public client companies. It also assists client companies in evaluating, structuring and negotiating joint ventures, strategic alliances, joint marketing agreements and other corporate transactions. It also provides advice on corporate finance, financial reporting and accounting operations. It offers a range of consulting services, such as reverse mergers and acquisitions, specific asset acquisitions, capital investment, debt investment, market development, transfer agent service advice, management and management placement, development and implementation of business models, and Internet marketplace and technology.

Closing Price
$0.002
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.002
Day's Low
0.002
Volume
2,500

UPDATE: Aurora Cannabis earnings claim it sold about a fifth of Canada's legal pot in opening quarter

5:55 pm ET February 11, 2019 (MarketWatch)
Print

Aurora Cannabis Inc. sold about one-fifth of Canada's recreational marijuana in the first quarter of legal availability, the company said Monday. The company's shares were up less than 1% in after-hours trading following the release Monday afternoon. Aurora reported a fiscal second-quarter loss of C$237.8 million on revenue of C$54.2 million, with the large losses reflecting a sharp decline in Aurora's investments in other pot companies. Not enough analysts track Aurora to produce a solid consensus; shares declined after the company said in January that it expected quarterly revenue would be C$50 million to C$55 million. Last year in the fiscal second quarter, Aurora reported earnings of C$7.7 million on revenue of C$11.7 million. That was before legal recreational weed was available in Canada, though: The fiscal second quarter reported includes the Oct. 17 launch of marijuana sales through the end of the year. "Based on available data released by Health Canada for the Q2 2019 period, Aurora accounted for approximately 20% of all consumer sales across the country," the company stated in Monday's release. Aurora shares closed with a 5.5% decline at $7.17 Monday, but have gained 57.8% in the past six months, as the S&P 500 index has declined 4.4%.

-Jeremy C. Owens; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

February 11, 2019 17:55 ET (22:55 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.